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ABSTRACT
We report the discovery, tissue distribution and pharmacolog-
ical characterization of a novel receptor, which we have named
H4. Like the three histamine receptors reported previously (H1,
H2, and H3), the H4 receptor is a G protein-coupled receptor
and is most closely related to the H3 receptor, sharing 58%
identity in the transmembrane regions. The gene encoding the
H4 receptor was discovered initially in a search of the GenBank
databases as sequence fragments retrieved in a partially se-
quenced human genomic contig mapped to chromosome 18.
These sequences were used to retrieve a partial cDNA clone
and, in combination with genomic fragments, were used to
determine the full-length open reading frame of 390 amino
acids. Northern analysis revealed a 3.0-kb transcript in rat testis
and intestine. Radioligand binding studies indicated that the H4
receptor has a unique pharmacology and binds [3H]histamine
(Kd 5 44 nM) and [
3H]pyrilamine (Kd 5 32 nM) and several psy-
choactive compounds (amitriptyline, chlorpromazine, cyprohepta-
dine, mianserin) with moderate affinity (Ki range of 33–750 nM).
Additionally, histamine induced a rapid internalization of HA-
tagged H4 receptors in transfected human embryonic kidney 293
cells.
Histamine is a monoamine neurotransmitter thus far
known to activate three G protein-coupled receptors
(GPCRs), the H1, H2, and H3 receptors (Hill et al., 1997).
Although molecular cloning has made possible the identifi-
cation, isolation, and characterization of the majority of
known GPCRs, the histamine receptor subtypes have proven
more difficult to identify. The first two histamine receptor
genes cloned were H1 (Yamashita et al., 1991) and H2 (Gantz
et al., 1991). The identification of the H3 receptor came
nearly a decade later (Lovenberg et al., 1999). Collectively,
the H1, H2, and H3 receptors share less than 35% identity
with one another and each has greater sequence identities
with other aminergic receptors. Thus, the histamine receptor
gene family is significantly divergent and may have evolved
from different ancestral genes (Leurs et al., 2000). In addi-
tion, there is evidence that multiple subtypes of the H3
receptor may exist. Pharmacological studies performed on
membranes extracted from rat brain tissue revealed two
classes of H3 binding sites (West et al., 1990; Leurs et al.,
1996). However, efforts to clone a second H3 receptor subtype
in the brain have thus far been unsuccessful.
Through molecular cloning techniques, we have identified
numerous novel GPCRs, including many subtypes not sus-
pected to exist on the basis of pharmacology. Over the past
decade, our cloning efforts have identified a number of GPCR
genes, including genes encoding such receptors as the cystei-
nyl leukotriene CysLT2 (Heise et al., 2000), galanin GalR2
and GalR3 (Kolakowski et al., 1998), thyrotropin-releasing
hormone TRH-R2 (O’Dowd et al., 2000), uridine nucleotide
receptor UNR (Nguyen et al., 1995), as well as a large cohort
of orphan GPCRs for which the endogenous ligands remain to
be elucidated (Marchese et al., 1999; Lee et al., 2001). In a
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scan of the GenBank high-throughput genomic sequence
(HTGS) database, we identified a small DNA fragment that
had greatest homology to the known histamine receptor
genes. Here we report the discovery, tissue distribution, and
pharmacological characterization of human DNA encoding a
receptor, H4. H4 receptor mRNA had discrete and limited
expression in rat testis and intestine. Although the H4 re-
ceptor was most closely related to the H3 receptor [58%
identity in the transmembrane (TM) regions], it seemed to
possess a unique pharmacology, with highest affinity for
psychoactive drugs (amitriptyline, chlorpromazine) with a
tricyclic structure.
Materials and Methods
Database Searching. A customized search was used to query the
GenBank HTGS database of high-throughput genomic sequences
maintained by the National Center for Biotechnology Information
(NCBI) with the sequences of various GPCRs, using the FAST_PAN
program (Retief et al., 1999).
Screening and Construction of the H4 Receptor Gene. Par-
tial sequences encoding the H4 receptor were used to design primers
to PCR-amplify H4-encoding fragments from human genomic DNA.
A fragment encoding the start methionine to TM2 was amplified
using primers P1 (59-ATGCCAGATACTAATAGCACAATC-39) and
P2 (59-CACAAAGAAGTCAGAGATGG-39) and another fragment en-
coding from TM5 to TM6 using primers P3 (59-TGGTACATCCTT-
GCCATC-39) and P4 (59-TATGGAGCCCAGCAAACAG-39). PCR
products were extracted with phenol/chloroform, precipitated with
ethanol, and electrophoresed on a low-melting agarose gel. DNA in
the expected size range were excised from the gel, ligated into the
EcoRV site of the pBluescript vector (Stratagene, La Jolla, CA), and
then the sequence was determined. H4 receptor-encoding fragments
were used to screen human and rat genomic libraries (CLONTECH,
Palo Alto, CA) and a human testis cDNA library (CLONTECH), as
described previously (Marchese et al., 1994). Isolated phages from
the human and rat genomic libraries were purified and subcloned,
and the sequence was determined as described previously (Marchese
et al., 1994). Isolated phages from the human cDNA library were
subjected to PCR amplification using primers specific for regions
flanking the insert of the lgt10 library vector, subcloned, and se-
quenced.
A DNA fragment encoding the full-length human H4 receptor was
amplified by PCR in three stages using isolated human genomic and
cDNA library phage as templates. In stage 1, three overlapping
fragments (A, B, and C), together encoding the full-length H4 recep-
tor, were PCR-amplified as follows. Fragment A was obtained using
primers P5 (59-CATCATTTGATGTGATGCCA-39) and P6 (59-CAAA-
GGAATGGAGATCACACCCACAAAGAAGTCAGA-39) from an iso-
lated genomic library phage obtained with the Met-TM2 encoding
DNA probe. Fragment B was obtained using primers P7 (59-GT-
GATCTCCATTCCTTTG-39) and P8 (59-TCCAATAAATATTCAT-39)
from an isolated testis cDNA library phage. Fragment C was ob-
tained using primers P9 (59-TGGTACATCCTTGCCATC-39) and P10
(59-GAGGTGAGAAAATTGTC-39) from an isolated genomic library
phage obtained with the TM5–6 encoding DNA probe. In stage 2,
fragments B and C were joined by PCR using primers P7 and P10. In
stage 3, fragments A and B/C were joined together using primer P5
and P10 to obtain a fragment with a length of ;1200 base pairs
encoding the full-length H4 receptor. DNA encoding a hemagglutinin
(HA) epitope tag (YPYDVPDYA) was inserted after the start methi-
onine codon using PCR mutagenesis. This DNA was ligated into the
EcoRV site of the mammalian expression vector pcDNA3 (Invitro-
gen, Carlsbad, CA) and its sequence was determined.
Northern Expression Analyses. mRNA from various human
and rat tissues were extracted as described previously (Marchese et
al., 1994). Briefly, poly(A)1 RNA was isolated using oligo(dT) cellu-
lose spin columns (Pharmacia, Uppsala, Sweden), denatured and
size fractionated on a 1% formaldehyde agarose gel, transferred onto
nylon membrane, and immobilized by UV irradiation. The blots were
hybridized with 32P-labeled DNA fragments encoding the human
and rat H4 receptor, washed with 23 standard saline/phosphate/
EDTA and 0.1% SDS at 50°C for 20 min and with 0.13 standard
saline/phosphate/EDTA and 0.1% SDS at 50°C for 2 h and exposed to
X-ray film at 270°C in the presence of an intensifying screen.
Radioligand Binding Studies. For these studies, the HA-
tagged H4 receptor was transiently transfected into human embry-
onic kidney 293 cells into 100-mm plates using FUGENE-6 (Roche
Fig. 1. Alignment of four human his-
tamine receptors H1, H2, H3 and H4.
Residues identical among the recep-
tors are shaded. Numeric amino acid
positions are indicated on the right.
The presence of introns interrupting
the H4 sequence are shown as “”. H4
sequence data has been deposited in
GenBank (accession number
AY008280).
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Molecular Biochemicals, Rotkreuz, Switzerland) at a 6:1 ratio of
FUGENE/DNA as detailed previously (Shapiro et al., 2000). At 72 h
after transfection, cells were harvested and membranes prepared as
described previously (Shapiro et al., 2000); membranes were stored
as pellets at 280°C until use. Radioligand binding assays were
performed in a total volume of 500 ml in 50 mM Tris-Cl, 0.5 mM
EDTA, pH 7.4, with 15 nM [3H]pyrilamine in the 96-well format.
After a 1-h incubation at room temperature, membranes were har-
vested by rapid filtration with a Brandel Harvester followed by two
quick washes of ice-cold binding buffer. After drying, filters were
placed into scintillation fluid and quantified by liquid scintillation
spectrometry. Data were analyzed using GraphPad Prism (Graph-
Pad Software, San Diego, CA) and data presented represents the
mean 6 S.E.M. of computer-derived estimates of at least three sep-
arate experiments, each done in duplicate. For inhibition studies, 12
concentrations of unlabeled ligand spanning 6 log units of test drug
were used; for saturation studies, six concentrations of labeled ligand
spanning 3 log units were used.
Immunoblot Analysis. The HA-tagged H4 receptor was tran-
siently transfected into COS-7 monkey kidney cells (American Type
Culture Collection, Manassas, VA) and membranes prepared from
these cells as described previously (Lee et al., 2000). In brief, tissues
were solubilized in sample buffer consisting of 50 mM Tris-HCl, pH
6.5, 1% SDS, 10% glycerol, 0.003% bromphenol blue, and 10% 2-mer-
captoethanol. The samples were subjected to polyacrylamide gel
electrophoresis with 12% acrylamide gels and electroblotted onto
nitrocellulose as described previously (Ng et al., 1996). HA-tagged
H4 immunoreactivity was revealed with the 3F10 rat monoclonal
antibody (Roche, Laval, Quebec).
Internalization Studies. For these studies, HA-tagged H4 re-
ceptors were transfected into HEK-293 cells as described above into
100-mm plates. At 24 h after transfection, cells were split into
24-well plates containing poly-lysine-coated glass cover slips using
Dulbecco’s modified Eagle’s medium containing 10% dialyzed fetal
calf serum. The medium was replaced 24 h later with serum-free
Dulbecco’s modified Eagle’s medium. The next day, cells were ex-
posed to 100 mM histamine for 0, 2, 5, or 15 min and then fixed with
freshly prepared 4% paraformaldehyde in PBS for 30 min at room
temperature. Cells were then permeabilized on ice (0.2% Triton
X-100 in ice-cold PBS) for 20 min and then incubated with blocking
buffer (5% nonfat dry milk, 2% bovine serum albumin in PBS) for 1 h
and then incubated with a 1:2000 dilution of monoclonal anti-HA
antibody in blocking buffer overnight at 4°C. The next day, after
extensive washing in room temperature PBS, cells were incubated
with secondary antibody (BODIPY-labeled goat anti-mouse; 1:250
dilution in blocking buffer) for 1 h, washed extensively with PBS, and
prepared for confocal microscopy as detailed previously (Berry et al.,
1996; Kristiansen et al., 2000). Internalization was quantified as
described previously (Berry et al., 1996; Willins et al., 1999).
Results and Discussion
As part of our ongoing search of novel genes encoding
GPCRs, we queried the GenBank sequence databases main-
tained by NCBI with known GPCR sequences. A search with
the histamine H3 receptor sequence retrieved partial se-
quences of a novel GPCR-encoding gene in an unfinished
sequence of a human contig mapped to chromosome 18 (Gen-
Bank accession number AC007922). The retrieved sequence
was obtained in three separate fragments, including one
fragment that seemed to encode the receptor from the start
methionine to TM2, another fragment encoding TM3, and a
third fragment encoding TM5 through TM7 of a novel GPCR-
like gene. These partial sequences were used to design prim-
ers for PCR amplification of human genomic DNA. Two frag-
Fig. 2. Representative schematic of
the human H4 receptor embedded in a
cell membrane (box). Transmembrane
regions are numbered and depicted
with a top (extracellular)/bottom (in-
tracellular) orientation. N-linked gly-
cosylation sites are indicated in blue.
Amino acids in red represent residues
shared with the histamine receptor
H3.
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ments of DNA, encoding the start methionine to TM2 and
TM5 to TM6, respectively, were obtained and used as probes
to screen a human genomic library. The Met-TM2 probe
retrieved two phages encoding the 59 end of the novel gene
from the start methionine to TM2, whereas the TM5-TM6
probe retrieved four phages encoding the 39 end of the gene
from TM5 to the stop codon.
Using the TM5-TM6 probe, we screened several tissues by
Northern analyses, which revealed a 3.0-kb signal in rat
testis. A human testis cDNA library was screened with both
probes, which isolated two identical phages encoding the
sequence from TM2 to TM6 of the gene. The sequences were
identical in regions of overlap, confirming them to be partial
sequences of the same gene. A comparison of the cDNA
fragment to the GenBank genomic sequence revealed two
introns interrupting the H4 receptor sequence. The first in-
tron was ;8 kb in length and located within the TM2-encod-
ing region (interrupting the translated sequence “LNLAISD-
FFVG. . . VISIPLYIPH”). The second intron was downstream
in the region encoding the second intracellular loop (inter-
rupting the translated sequence “DRYLSVSNA. . . VSYR-
TQHTGV”). The length of this intron could not be deter-
mined, because the GenBank genomic sequence was
incomplete.
A BLASTX search of the GenBank database with this
novel DNA sequence revealed the greatest overall identity
with the histamine receptor H3 (;40%) and, more distantly,
with other amine-type receptors of the GPCR family (,30%).
As also reported with the H3 receptor (Lovenberg et al.,
1999), this novel receptor shared greater identity with other
amine receptors including the serotonin, adrenergic, dopa-
mine, and muscarinic receptors (; 25%) than the histamine
receptors H1 or H2 (;20%). An alignment with the known
histamine receptors (Fig. 1) revealed a higher sequence sim-
ilarity to the H3 receptor (58% in the TM regions) than to the
H1 and H2 receptors (26 and 27% in the TM regions, respec-
tively). It has been determined from their sequence similar-
ities and phylogenetic analyses that the members of the
histamine receptor family may have evolved from different
ancestral genes and, through convergent evolution, acquired
the residues to recognize and bind histamine (Leurs et al.,
2000). This novel receptor, which we have named H4, seems
to be a novel member of the histamine receptor subfamily,
with closest relation to the H3 receptor. The amino acid
sequence of the H4 receptor revealed many conserved resi-
dues and motifs found within the GPCR family (Fig. 2).
Among these is an aspartic acid residue in TM 3 that is
conserved in all cationic amine receptors and has been shown
to be important in binding various amines to GPCRs (Sava-
rese and Fraser, 1992). In addition, the human Met-TM2
probe was used to screen a rat genomic library, which re-
trieved a phage encoding the 59 end of the novel gene from the
start methionine to TM2. This fragment shared 71% identity
(83% in the TM regions) to the human H4 sequence, reveal-
ing a rat H4 ortholog.
The human Met-TM2 and TM5-TM6 probes were used in
Northern analyses of various human and rat tissues. In the
rat, the TM5-TM6 probe revealed a single transcript of 3 kb
Fig. 3. Northern blot analysis of the distribution of H4 mRNA in various
rat tissues. Each lane contained 10 mg of poly(A)1 RNA.
Fig. 4. Saturation binding studies of [3H]histamine (A) and [3H]pyril-
amine (B) specific binding in membranes prepared from HEK-293 cells
transiently transfected with H4 cDNA. Shown are typical results from
experiment replicated three (A) and two times (B), with data representing
mean of duplicate determinations. The curve represents the theoretical
fit of the data A) (Kd 5 44 nM; Bmax 5 235 fmol/mg) and B) (Kd 5 32 nM;
Bmax 5 437 fmol/mg). Nonspecific binding was determined with 100 mM
mianserin.
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in the testis (Fig. 3). The rat DNA fragment encoding from
the start methionine to TM2 was used in Northern analyses
of various rat tissues, revealing a 3-kb transcript in intestine
(data not shown). The H3 and H4 receptors had significantly
different mRNA expression distributions. H4 mRNA was de-
tected in two peripheral tissues (with no detectable levels in
brain or various peripheral tissues, including heart, stomach,
small intestine, kidney, or liver). In contrast, H3 mRNA has
been reported to be abundant in the brain (Lovenberg et al.,
1999). Thus, H4 is not likely to be the H3-subtype character-
ized previously in brain tissue (West et al., 1990; Leurs et al.,
1996), which suggests that yet another histamine receptor
subtype remains unidentified.
To test the H4 receptor for pharmacological characteriza-
tion, we constructed a full-length open reading frame by
individually amplifying and joining the three H4-encoding
fragments by PCR. The receptor was expressed in HEK-293
cells, and a variety of tritiated ligands including [3H]hista-
mine (histamine receptor nonselective), [3H]pyrilamine (H1
receptor-selective), and [3H]tiotidine (H2 receptor-selective)
were tested against unlabeled ligands including mianserin,
cyproheptadine, histamine, and clozapine. Specific binding
obtained with [3H]histamine (44 nM) or [3H]pyrilamine
(5–20 nM) and mianserin (100 mM) represented between 40
and 75% of total binding. Saturation binding studies per-
formed with [3H]histamine and [3H]pyrilamine indicated re-
spective Kd values of 44 and 32 nM and respective Bmax
values of 235 and 437 fmol/mg of membrane protein (Fig. 4).
No specific [3H]histamine or [3H]pyrilamine binding was ob-
served with untransfected HEK-293 cells.
Competition binding studies with various selective and
nonselective histaminergic compounds were demonstrated.
Typical data are shown in Fig. 5 and summarized in Table 1.
The highest affinities were for amitriptyline and chlorprom-
azine, which are tricyclic compounds that have high affinity
for the H1 histamine receptor (see on-line database at:
http://pdsp.cwru.edu/pdsp.asp). Doxepin, cinnarizine, and
promethazine (H1-selective antagonists) also displayed high
affinity for the H4 receptor. Imetit (H3-selective agonist) and
dimaprit (H2-selective agonist) had weak affinities for the H4
receptor, whereas mianserin (an H1 and H2 antagonist),
cyproheptadine (a nonselective histamine/serotonin antago-
nist), and clozapine (an atypical antipsychotic drug with high
affinity for a large number of receptors) had moderate affin-
ities. The pharmacological profile of the H4 receptor is dis-
tinct from the histamine receptors (Table 1).
An HA epitope tag-encoding sequence was inserted after
the start methionine for Western blot visualization. This
plasmid was transiently transfected into COS-7 cells. Immu-
noblot analyses of membranes from these cells revealed high
expression of the H4 receptor (Fig. 6A), with bands at 44 kDa,
85 kDa, and higher molecular mass species. The 44-kDa band
matched the expected mass of the unglycosylated receptor
and the 85-kDa band matched the glycosylated form. The
bands .250 kDa represent oligomeric receptor species (Lee
et al., 2000). The functional activity of the HA-tagged H4
receptor was examined by measuring histamine-induced in-
ternalization. As shown in Fig. 6B, exposure to 100 mM
Fig. 5. Two sets (A and B) of competition binding of [3H]pyrilamine with
various ligands in membranes prepared from HEK-293 cells transiently
transfected with H4 cDNA. Shown are typical results from competition
binding experiments using 20 nM [3H]pyrilamine and various concentra-
tions of unlabeled ligands. Also shown are typical results obtained with
untransfected HEK-293 cells studied in parallel (A).
TABLE 1
Ligand affinities for the H4 receptor
Data represent mean 6 S.E. for two to four separate experiments. Twelve different
concentrations spanning 6 log units of test drug were used to displace 15 nM
[3H]pyrilamine.
2LogEC50 (Ki) Hill Coefficient
nM
Amitriptyline 7.31 6 0.26 (33.6) 0.8
Chlorpromazine 7.13 6 0.29 (50.2) 0.7
Doxepin 6.79 6 0.13 (105.9) 0.6
Cinnarizine 6.73 6 0.20 (141.6) 0.7
Promethazine 6.71 6 0.19 (150.2) 0.6
Cyproheptadine 6.53 6 0.09 (201.5) 0.9
Clemizole 6.16 6 0.12 (402.2) 0.5
Mianserin 5.96 6 0.40 (750.0) 0.9
Clozapine 5.90 6 0.22 (849.6) 1.2
Chlorpheniramine 5.39 6 0.16 (2910.0) 1.1
Histamine 5.30 6 0.04 (3442.3) 0.5
Imetit 5.25 6 0.44 (3795.6) 0.2
Pheniramine 5.21 6 0.47 (4184.0) 0.2
Dimaprit 4.76 6 0.19 (11812.7) 0.4
a-Methylhistamine .10,000 Undetermined
Cimetidine .10,000 Undetermined
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histamine caused an internalization of H4 receptors from the
plasma membrane to intracellular sites. Quantification re-
vealed a rapid internalization of H4 receptors with signifi-
cant internalization at 2 min after agonist exposure (Fig. 6C).
These results indicated that the surface expression of the H4
receptor is functionally regulated by histamine exposure in a
time-dependent fashion.
During the preparation of this article, other researchers
(Oda et al., 2000) also reported the identification of a cDNA
encoding a novel histamine receptor. This cDNA sequence
varied from our sequence at three nucleotide positions, which
translated into differences in three amino acids. Specifically,
Ala138, His206, and Gln253 (as found in our sequence) were
replaced by valine and two arginines, respectively. In the
study by Oda et al., expression analyses revealed signals in
peripheral blood leukocytes, small intestine, spleen and co-
lon, and no expression in the brain. In addition, they reported
histamine signaling through the novel receptor to be pertus-
sis toxin-sensitive, suggesting a Gi/o pathway of activation.
For our receptor, we examined several second messenger-
effector systems. We were not able to demonstrate H4 recep-
tor-mediated inhibition of forskolin-stimulated adenylyl cy-
clase, alterations in phosphoinositide hydrolysis, or mitogen-
activated protein kinase phosphorylation (extracellular
signal-regulated kinase 1/2 phosphorylation) in HEK-293
cells.
In conclusion, we report the discovery of a novel histamine
receptor, H4. Previously, it was observed that histamine
receptors shared greater sequence similarities with other
biogenic amine-binding GPCRs than with one another. H4
shared highest sequence similarity with the previously re-
ported histamine H3 receptor. In combination with the H1,
H2, and H3 receptors, this receptor, with its unique distri-
bution and pharmacology, will undoubtedly provide further
insight into the physiological functions and therapeutic ap-
plications of this receptor family.
Fig. 6. A, immunoblot analysis of membranes from mock-transfected COS-7 cells (lane 1) and COS-7 cells expressing the HA-H4 receptor (lane 2).
Membrane protein (25 mg) was used in each lane. Arrows indicate the unglycosylated (bottom) and glycosylated (top) receptor. B) histamine-induced
internalization of the H4 receptor in HEK-293 cells. Shown are representative confocal micrographs in which HA-tagged H4 receptors were examined
in cells exposed to vehicle (PBS) or 100 mM histamine for 5 min and then prepared for microscopy as described previously (Berry et al., 1996; Willins
et al., 1999; Kristiansen et al., 2000). Arrowheads and arrows indicate cell-surface and internalized receptors, respectively. C, histamine-induced
time-dependent internalization of the H4 receptor in HEK-293 cells. Shown are the mean 6 S.E.M. of the percentage internalization of HA-tagged H4
receptors in HEK-293 cells (n 5 20–30 cells/time point) after exposure to histamine (100 mM) for various time periods. ***significantly different
compared with 0-min value (P , 0.0001).
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